Medbox Applauds FINRA’s Warning on Marijuana Stocks

By: Jeremy Morris, Associate Editor,  USDR

Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced their support of a statement issued by the Financial Industry Regulatory Authority (FINRA), warning about possible stock scams in the medical marijuana  industry.

“Medical marijuana is legal in almost 20 states, and recreational use of the drug was recently legalized in two states. As a result, the cannabis business has been getting a lot of attention – including the attention of scammers,” the report stated. “Like many investment scams, pitches for marijuana stocks may arrive in a variety of ways – from faxes to email or text message invitations, to webinars, infomercials, tweets or blog  posts.”

Medbox, a leader in providing software and systems that improve compliance, increase transparency, accountability, and enhance security of medicines of all types, is in support of FINRA’s statements and has taken a similar stance in prior press  releases.

“We are in a period that is like the Gold Rush,” Dr. Bruce Bedrick, CEO of Medbox commented. “Unfortunately, there are companies and individuals that prey on investors looking to enter this fast-growing market,” he added. “We want these fly-by-night operations out of our industry, and support any regulatory authority in calling attention to the  problem.”

Medbox never engages in promotions or solicitations to sell their stock. In fact, the company does not even have an investor relations firm it works with and relies on media attention to organically promote the stock through genuine market  interest.

“We are in this business for the long haul,” Bedrick continued. “Our effort in becoming the most credible marijuana ancillary services public company has paid off for Medbox and its shareholders. Quarter after quarter we post solid revenue numbers, have an ever expanding business model, and we are the first company in the sector with a working business model while never touching the drug itself. We look forward to the increased scrutiny that goes along with being a fully reporting SEC  company.”

The company points out that the FINRA tips highlighted in the article are extremely helpful for investors to ascertain which marijuana related stocks are  viable.

If you or a loved one wants to quit using marijuana, keep in mind that there are marijuana abuse support groups that will be able to help you  out.

All opinions expressed on USDR are those of the author and not necessarily those of US Daily Review.

Leave a comment

Your email address will not be published.


*